Abstract
One of the essential issues in systems biology is to identify fundamental principles that govern living organisms at the system level. In this chapter, I argue that robustness is a fundamental feature of living systems where its relationship with evolution-trade-offs among robustness, fragility, resource demands, and performance-provides a possible framework for how biological systems have evolved and been organized. In addition, diseases can be considered as a manifestation of fragility of the system. In some cases, such as cancer, the disease state establishes its own robustness against therapeutic interventions. Understanding robustness and its intrinsic properties will provide us with a more profound understanding of biological systems, their anomalies, and countermeasures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agrawal AA (2001) Phenotypic plasticity in the interactions and evolution of species. Science 294:321–326
Alon U, Surette MG, Barkai N et al. (1999) Robustness in bacterial chemotaxis. Nature 397:168–171
Baisse B, Bouzourene H, Saraga P et al. (2001) Intratumor genetic heterogeneity in advanced human colorectal adenocarcinoma. Int J Cancer 93:346–352
Bak P, Tang C, Weisenfeld K et al. (1988) Self-organized criticality. Phys Rev A 38:364–374
Barabasi AL, Oltvai ZN (2004) Network biology: understanding the cell’s functional organization. Nat Rev Genet 5:101–113
Barkai N, Leibler S (1997) Robustness in simple biochemical networks. Nature 387:913–917
Bertalanffy LV (1968) General system theory. George Braziller, New York
Bhalla US, Iyengar R (1999) Emergent properties of networks of biological signaling pathways. Science 283:381–387
Bingle L, Brown NJ, Lewis CE et al. (2002) The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196:254–265
Bissell MJ, Radisky D (2001) Putting tumours in context. Nat Rev Cancer 1:46–54
Carlson JM, Doyle J (1999) Highly optimized tolerance: a mechanism for power laws in designed systems. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 60:1412–1427
Carlson JM, Doyle J (2002) Complexity and robustness. Proc Natl Acad Sci U S A 99Suppl 1:2538–2545
Chen KC, Calzone L, Csikasz-Nagy N et al. (2004) Integrative analysis of cell cycle control in budding yeast. Mol Biol Cell 15:3841–3862
Csete ME, Doyle J (2004) Bow ties, metabolism and disease. Trends Biotechnol 22:446–450
Csete ME, Doyle JC (2002) Reverse engineering of biological complexity. Science 295:1664–1669
De Visser J, Hermission J, Wagner GP et al. (2003) Evolution and detection of genetics robustness. Evolution 57:1959–1972
Dropulic B, Hermankova M, Pitha PM et al. (1996) A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread. Proc Natl Acad Sci U S A 93:11103–11108
Eldar A, Dorfman R, Weiss D et al. (2002) Robustness of the BMP morphogen gradient in Drosophila embryonic patterning. Nature 419:304–308
Ferrell JE Jr (2002) Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. Curr Opin Cell Biol 14:140–148
Frigyesi A, Gisselsson D, Mitleman F et al. (2003) Power law distribution of chromosome aberrations in cancer. Cancer Res 63:7094–7097
Fujii H, Yoshida M, Gong ZX et al. (2000) Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. Cancer Res 60:114–120
Gerhart J, Kirschner M (1997) Cells, embryos, and evolution: toward a cellular and developmental understanding of phenotypic variation and evolutionary adaptability. Blackwell Science, Malden, MA
Gonzalez-Garcia I, Sole RV, Costa J et al. (2002) Metapopulation dynamics and spatial heterogeneity in cancer. Proc Natl Acad Sci U S A 99:13085–13089
Gorunova L, Dawiskiba S, Andren-Sandberg A et al. (2001) Extensive cytogenetic heterogeneity in a benign retroperitoneal schwannoma. Cancer Genet Cytogenet 127:148–154
Gorunova L, Hoglund M, Andren-Sandberg A et al. (1998) Cytogenetic analysis of pancreatic carcinomas: intratumor heterogeneity and nonrandom pattern of chromosome aberrations. Genes Chromosomes Cancer 23:81–99
Guelzim N, Bottani S, Bourgine P et al. (2002) Topological and causal structure of the yeast transcriptional regulatory network. Nat Genet 31:60–63
Harris AL (2002) Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2:38–47
Hasty J, McMillen D, Collins JJ (2002) Engineered gene circuits. Nature 420:224–230
Hochhaus A (2003) Cytogenetic and molecular mechanisms of resistance to imatinib. Semin Hematol 40[2 Suppl 3]:69–79
Hochhaus A, Kreil S et al. (2001) Roots of clinical resistance to STI-571 cancer therapy. Science 293:2163
Holmgren L, MS O’Reilly, Folkman J et al. (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1:149–153
Ideker T, Ozier O, Schwikowski B et al. (2002) Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 18[Suppl 1]: S233–S240
Ideker T, Thorsson V, Ranish JA et al. (2001) Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 292:929–934
Ihmels J, Friedlander G, Bergmann S et al. (2002) Revealing modular organization in the yeast transcriptional network. Nat Genet 31:370–377
Ingolia NT (2004) Topology and robustness in the Drosophila segment polarity network. PLoS Biol 2:E123
Juliano RL, Ling V (1976) Asurface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152–162
Kirschner M, Gerhart J (1998) Evolvability. Proc Natl Acad Sci U S A 95:8420–8427
Kitano H (2002a) Computational systems biology. Nature 420:206–210
Kitano H (2002b) Systems biology: a brief overview. Science 295:1662–1664
Kitano H (2003) Cancer robustness: tumour tactics. Nature 426:125
Kitano H (2004a) Biological robustness. Nat Rev Genet 5:826–837
Kitano H (2004b) Cancer as a robust system: implications for anticancer therapy. Nat Rev Cancer 4:227–235
Kitano H, Kimura T, Oda K et al. (2004) Metabolic syndrome and robustness trade-offs. Diabetes 53[Suppl 3]: S1–S10
Kitano H, Oda K (2006) Robustness trade-offs and host? Microbial symbiosis in the immune system. Molecular systems biology. Nature Publishing Group and EMBO, Heidelberg
Lahav G, Rosenfeld N, Sigal A et al. (2004) Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat Genet 36:147–50
Lamport L, Shostak R, Pease M et al. (1982) The Byzantine generals problem. ACM Transa Prog Lang Sys 4:382–401
Lengauer C, KW Kinzler, Vogelstein B et al. (1998) Genetic instabilities in human cancers. Nature 396:643–649
Li R, Sonik A, Stindl R et al. (2000) Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. Proc Natl Acad Sci U S A 97:3236–3241
Little JW, DP Shepley, Wert DW et al. (1999) Robustness of a gene regulatory circuit. EMBO J 18:4299–4307
Meir E, G von Dassow, Munro E et al. (2002) Robustness, flexibility, and the role of lateral inhibition in the neurogenic network. Curr Biol 12:778–786
Morohashi M, AE Winn, Borisuk MT et al. (2002) Robustness as a measure of plausibility in models of biochemical networks. J Theor Biol 216:19–30
Murray C (1995) Tumour dormancy: not so sleepy after all. Nat Med 1:117–118
Nooter K, Herweijer H (1991) Multidrug resistance (mdr) genes in human cancer. Br J Cancer 63:663–669
Owen MR, HM Byrne, Lewis CE et al. (2004) Mathematical modelling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites. J Theor Biol 226:377–391
Queitsch C, TA Sangster, Lindquist S et al. (2002) Hsp90 as a capacitor of phenotypic variation. Nature 417:618–624
Rasnick D (2002) Aneuploidy theory explains tumor formation, the absence of immune surveillance, and the failure of chemotherapy. Cancer Genet Cytogenet 136:66–72
Rutherford SL (2003) Between genotype and phenotype: protein chaperones and evolvability. Nat Rev Genet 4:263–274
Rutherford SL, Lindquist S (1998) Hsp90 as a capacitor for morphological evolution. Nature 396:336–342
Schlichting C, Pigliucci M (1998) Phenotypic evolution: a reaction norm perspective. Sinauer Associates, Inc., Sunderland, MA
Schlosser G, Wagner G (eds) (2004) Modularity in development and evolution. The University of Chicago Press, Chicago
Sharp FR, Bernaudin M (2004) HIF1 and oxygen sensing in the brain. Nat Rev Neurosci 5:437–448
Siegal ML, Bergman A (2002) Waddington’s canalization revisited: developmental stability and evolution. Proc Natl Acad Sci U S A 99:10528–10532
Sole RV (2003) Phase transitions in unstable cancer cell populations. Eur Phys J B:117–123
Takahashi Y, Nishioka K (1995) Survival without tumor shrinkage: re-evaluation of survival gain by cytostatic effect of chemotherapy. J Natl Cancer Inst 87:1262–1263
Tischfield JA, Shao C (2003) Somatic recombination redux. Nat Genet 33:5–6
Tsuruo T, Iida H, Tsukagoshi S et al. (1981) Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967–1972
Tyson JJ, Chen K, Novak B (2001) Network dynamics and cell physiology. Nat Rev Mol Cell Biol 2:908–916
Uhr JW, RH Scheuermann, Street NE et al. (1997) Cancer dormancy: opportunities for new therapeutic approaches. Nat Med 3:505–509
Von Dassow G, Meir E, et al. (2000) The segment polarity network is a robust developmental module. Nature 406:188–192
Waddington CH (1957) The strategy of the genes: a discussion of some aspects of theoretical biology. Macmillan, New York
Wagner GP, Altenberg L (1996) Complex adaptations and the evolution of evolvability. Evolution 50:967–976
Weinberger LS, DV Schaffer, Arkin AP et al. (2003) Theoretical design of a gene therapy to prevent AIDS but not human immunodeficiency virus type 1 infection. J Virol 77:10028–10036
Wiener N (1948) Cybernetics: or control and communication in the animal and the machine. MIT Press, Cambridge
Yi TM, Huang Y, Simon MI et al. (2000) Robust perfect adaptation in bacterial chemotaxis through integral feedback control. Proc Natl Acad Sci U S A 97:4649–4653
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kitano, H. (2007). The Theory of Biological Robustness and Its Implication in Cancer. In: Bringmann, P., Butcher, E.C., Parry, G., Weiss, B. (eds) Systems Biology. Ernst Schering Research Foundation Workshop, vol 61. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-31339-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-540-31339-7_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-31338-0
Online ISBN: 978-3-540-31339-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)